Abstract
Ninety-two patients were entered in a double-blind controlled trial of long-acting quinidine bisulphate for the maintenance of sinus rhythm following DC reversion of atrial fibrillation. By random selection two statistically comparable groups of patients were obtained, a control group being given a placebo and a treated group quinidine bisulphate 1·5 g. per day in two 12-hourly doses. Thirty-seven patients were followed up in the control group and twenty-eight patients in the treated group. The maintenance of sinus rhythm in the treated group was significantly longer than in the control group, especially during the first three months. The mean serum quinidine level in the treated group was 2·2±0·3 (SEM) mg. per litre. There was one death among the patients treated with quinidine, which may have been due to quinidine toxicity caused by a high serum quinidine level.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BALL R. E., SOKOLOW M. Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration. Circulation. 1956 Oct;14(4 Pt 1):568–583. doi: 10.1161/01.cir.14.4.568. [DOI] [PubMed] [Google Scholar]
- CONN H. L., Jr, LUCHI R. J. SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT. Am J Med. 1964 Nov;37:685–699. doi: 10.1016/0002-9343(64)90018-x. [DOI] [PubMed] [Google Scholar]
- Chevalier H. A plea for atrial fibrillation. Am Heart J. 1966 Sep;72(3):423–425. doi: 10.1016/s0002-8703(66)80019-4. [DOI] [PubMed] [Google Scholar]
- EDGAR A. L., SOKOLOW M. Experiences with the photofluorometric determination of quinidine in blood. J Lab Clin Med. 1950 Sep;36(3):478–484. [PubMed] [Google Scholar]
- HURST J. W., PAULK E. A., Jr, PROCTOR H. D., SCHLANT R. C. MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION. Am J Med. 1964 Nov;37:728–741. doi: 10.1016/0002-9343(64)90021-x. [DOI] [PubMed] [Google Scholar]
- Hall J. I., Wood D. R. Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine. Br Heart J. 1968 Jan;30(1):84–90. doi: 10.1136/hrt.30.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Halmos P. B. Direct current conversion of atrial fibrillation. Br Heart J. 1966 May;28(3):302–308. doi: 10.1136/hrt.28.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOWN B., PERLROTH M. G., KAIDBEY S., ABE T., HARKEN D. E. "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. N Engl J Med. 1963 Aug 15;269:325–331. doi: 10.1056/NEJM196308152690701. [DOI] [PubMed] [Google Scholar]
- ORAM S., DAVIES J. P. FURTHER EXPERIENCE OF ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM: ANALYSIS OF 100 PATIENTS. Lancet. 1964 Jun 13;1(7346):1294–1298. doi: 10.1016/s0140-6736(64)91692-7. [DOI] [PubMed] [Google Scholar]
- Radford M. D., Evans D. W. Long-term results of DC reversion of atrial fibrillation. Br Heart J. 1968 Jan;30(1):91–96. doi: 10.1136/hrt.30.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rossi M., Lown B. The use of quinidine in cardioversion. Am J Cardiol. 1967 Feb;19(2):234–238. doi: 10.1016/0002-9149(67)90539-5. [DOI] [PubMed] [Google Scholar]
- SELZER A., WRAY H. W. QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS. Circulation. 1964 Jul;30:17–26. doi: 10.1161/01.cir.30.1.17. [DOI] [PubMed] [Google Scholar]
- Szekely P., Batson G. A., Stark D. C. Direct current shock therapy of cardiac arrhythmias. Br Heart J. 1966 May;28(3):366–373. doi: 10.1136/hrt.28.3.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- THOMSON G. W. Quinidine as a cause of sudden death. Circulation. 1956 Nov;14(5):757–765. doi: 10.1161/01.cir.14.5.757. [DOI] [PubMed] [Google Scholar]